These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 26976607)

  • 1. SARS-like WIV1-CoV poised for human emergence.
    Menachery VD; Yount BL; Sims AC; Debbink K; Agnihothram SS; Gralinski LE; Graham RL; Scobey T; Plante JA; Royal SR; Swanstrom J; Sheahan TP; Pickles RJ; Corti D; Randell SH; Lanzavecchia A; Marasco WA; Baric RS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3048-53. PubMed ID: 26976607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
    Ge XY; Li JL; Yang XL; Chmura AA; Zhu G; Epstein JH; Mazet JK; Hu B; Zhang W; Peng C; Zhang YJ; Luo CM; Tan B; Wang N; Zhu Y; Crameri G; Zhang SY; Wang LF; Daszak P; Shi ZL
    Nature; 2013 Nov; 503(7477):535-8. PubMed ID: 24172901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses.
    Zeng LP; Ge XY; Peng C; Tai W; Jiang S; Du L; Shi ZL
    Sci China Life Sci; 2017 Dec; 60(12):1399-1402. PubMed ID: 29134417
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.
    Menachery VD; Yount BL; Debbink K; Agnihothram S; Gralinski LE; Plante JA; Graham RL; Scobey T; Ge XY; Donaldson EF; Randell SH; Lanzavecchia A; Marasco WA; Shi ZL; Baric RS
    Nat Med; 2015 Dec; 21(12):1508-13. PubMed ID: 26552008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1.
    Qiao S; Wang X
    J Virol; 2024 Aug; 98(8):e0034224. PubMed ID: 39028202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.
    Sheahan T; Rockx B; Donaldson E; Corti D; Baric R
    J Virol; 2008 Sep; 82(17):8721-32. PubMed ID: 18579604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
    O'Keefe BR; Giomarelli B; Barnard DL; Shenoy SR; Chan PK; McMahon JB; Palmer KE; Barnett BW; Meyerholz DK; Wohlford-Lenane CL; McCray PB
    J Virol; 2010 Mar; 84(5):2511-21. PubMed ID: 20032190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
    J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
    Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
    Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human monoclonal antibody blocking SARS-CoV-2 infection.
    Wang C; Li W; Drabek D; Okba NMA; van Haperen R; Osterhaus ADME; van Kuppeveld FJM; Haagmans BL; Grosveld F; Bosch BJ
    Nat Commun; 2020 May; 11(1):2251. PubMed ID: 32366817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response.
    Zeng LP; Gao YT; Ge XY; Zhang Q; Peng C; Yang XL; Tan B; Chen J; Chmura AA; Daszak P; Shi ZL
    J Virol; 2016 Jul; 90(14):6573-6582. PubMed ID: 27170748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bat origin of human coronaviruses.
    Hu B; Ge X; Wang LF; Shi Z
    Virol J; 2015 Dec; 12():221. PubMed ID: 26689940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
    Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tracing the origins of SARS-COV-2 in coronavirus phylogenies].
    Sallard E; Halloy J; Casane D; van Helden J; Decroly É
    Med Sci (Paris); 2020; 36(8-9):783-796. PubMed ID: 32773024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
    Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
    Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction
    Zheng M; Zhao X; Zheng S; Chen D; Du P; Li X; Jiang D; Guo JT; Zeng H; Lin H
    Emerg Microbes Infect; 2020 Dec; 9(1):1567-1579. PubMed ID: 32602823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.
    Becker MM; Graham RL; Donaldson EF; Rockx B; Sims AC; Sheahan T; Pickles RJ; Corti D; Johnston RE; Baric RS; Denison MR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19944-9. PubMed ID: 19036930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.